Analysis of the Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Breast Cancer Patients Treated With Cyclin-Dependent Kinases 4 and 6 Inhibitors (CDKi): Limited T-Cell Immunity Despite Satisfactory Humoral Response
- Resource Type
- Source
- Subject
Messenger RNA biology business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Immunogenicity biochemical phenomena, metabolism, and nutrition medicine.disease Breast cancer Cyclin-dependent kinase Cancer research biology.protein T cell immunity Medicine business - Language